Rivaroxaban Impurity 213 CAS CATO-C4X-1090213
| CAS No. | CATO-C4X-1090213 |
| Molecular Formula | C11H8ClNO2 |
| Molecular Weight | 221.64 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Structurally, Rivaroxaban Impurity 213 (C11H8ClNO2) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. The molecule exhibits a degree of unsaturation (DBE) of 8.0, corresponding to approximately 8 ring(s) or double-bond equivalent(s). With a molecular weight of 221.64 g/mol, it falls into the medium-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
As a process- or degradation-related impurity, Rivaroxaban Impurity 213 (CAS CATO-C4X-1090213, C11H8ClNO2) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Rivaroxaban Impurity 213 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C11H8ClNO2 |
| Molecular Weight | 221.64 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | ≥95% |
| Storage | Store at 2-8°C, protect from light, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in chloroform, dichloromethane, ethyl acetate, DMSO |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 8.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 1 |
Related Rivaroxaban Standards
- Rivaroxaban Impurity 133 (CAS 130155-41-8)
- Rivaroxaban Impurity 7 (CAS 186348-58-3)
- Rivaroxaban Impurity 110 (CAS CATO-C4X-1090110)
- Rivaroxaban Impurity 113 (CAS 119835-88-0)
- Rivaroxaban Impurity 48 (CAS 62457-35-6)
- Rivaroxaban Impurity 37 (CAS 446292-04-2)
- Rivaroxaban Impurity 58 (CAS 845729-43-3)
- Rivaroxaban Impurity 59 (CAS 845729-41-1)
Recommended Standards
- (E)-N-{[5-(4-chlorophenyl)furan-2-yl]methylidene}hydroxylamine 2G-046 52507-66-1 (CAS 52507-66-1)
- Idarubicin Impurity 3 (CAS 16883-16-2)
- Propyl 4-methylbenzoate (CAS 6976-69-8)
- Darolutamide Impurity 50 (CAS CATO-C4X-310650)
- Ertapenem Dimer Form D Impurity (CAS 1199797-41-5)
- Lansoprazole Impurity 8 (CAS 127337-60-4)
- Roxatidine Impurity 46 (CAS 4764-13-0)
- (5-Methyl-1,2,4-oxadiazol-3-yl)(1-methyl-1h-pyrazol-4-yl)methanamine (CAS 1155536-36-9)
- Platinum(IV) bromide (CAS 68938-92-1)
- 1-Ethyl-4-(6-fluoro-5-methylpyridin-3-yl)piperidin-4-ol (CAS 1820674-37-0)
- Methyl (3R,4S)-1-benzyl-4-((tert-butoxycarbonyl)amino)pyrrolidine-3-carboxylate (CAS 1932828-96-0)
- 6-Bromo-3H-imidazo[4,5-b]pyridine-2-carboxylic acid (CAS 954217-62-0)
- 2-Cyclobutyl-5-ethynylthiophene (CAS 2304405-08-9)
- Des-Ser32-Tirzepatide (CAS CATO-CPTD788942)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com